SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

AstraZeneca expands AI partnership with Immunai in deal worth up to $37.5 million

The strong shekel is becoming Israel’s next economic crisis

Airport congestion pushes Israel to relocate American aircraft

Drive TLV's FastLane program completes 11th cohort with five deep-tech startups

Buzz

Most popular

Daily

Weekly

1

Kela raising $200 million at $1 billion valuation with backing from Bill Ackman and Eric Schmidt

2

From defense giants to startups: Israel reconsiders how it buys weapons

3

Five bidders advance in Nice’s $2.5 billion Actimize sale process

4

Cisco acquires AI security startup Astrix for $400 million

5

ZyG raises $60 million Series A at $500 million valuation just a year after launch

RedHill Biopharma

2 stories about RedHill Biopharma

Israel’s RedHill Biopharma testing oral pill that cures Covid-19 symptoms

28.02.21|Yafit Ovadia

Israeli pharmaceutical company creates treatment to help severe and moderately-ill patients; company generates $90 million in sales annually

RedHill's Public Offering Spooks Investors, Sends Stock Down

09.11.17|Dror Reich

The Nasdaq-listed biopharmaceutical company priced its shares at $5.5 per American Depositary Share, a third of its 2015 public offering price, and dropped nearly 30% by Wednesday market close